These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36255170)
1. Mucosal and systemic immune responses to Naidu A; Lulu S S Expert Rev Clin Immunol; 2022 Dec; 18(12):1307-1318. PubMed ID: 36255170 [TBL] [Abstract][Full Text] [Related]
2. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice. Fakoya B; Sit B; Waldor MK J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930 [TBL] [Abstract][Full Text] [Related]
3. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139. Kamruzzaman M; Kelly M; Charles RC; Harris JB; Calderwood SB; Akter A; Biswas R; Kaisar MH; Bhuiyan TR; Ivers LC; Ternier R; Jerome JG; Pfister HB; Lu X; Soliman SE; Ruttens B; Saksena R; Mečárová J; Čížová A; Qadri F; Bystrický S; Kováč P; Xu P; Ryan ET mSphere; 2021 Aug; 6(4):e0011421. PubMed ID: 34232076 [TBL] [Abstract][Full Text] [Related]
4. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. Liao J; Gibson JA; Pickering BS; Watnick PI mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145 [TBL] [Abstract][Full Text] [Related]
5. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines. Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947 [TBL] [Abstract][Full Text] [Related]
6. A review of the current status of enteric vaccines. Levine MM; Noriega F P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876 [TBL] [Abstract][Full Text] [Related]
7. Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae. Weil AA; Ellis CN; Debela MD; Bhuiyan TR; Rashu R; Bourque DL; Khan AI; Chowdhury F; LaRocque RC; Charles RC; Ryan ET; Calderwood SB; Qadri F; Harris JB mSphere; 2019 Aug; 4(4):. PubMed ID: 31434744 [No Abstract] [Full Text] [Related]
8. Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice. Sit B; Zhang T; Fakoya B; Akter A; Biswas R; Ryan ET; Waldor MK PLoS Negl Trop Dis; 2019 May; 13(5):e0007417. PubMed ID: 31150386 [TBL] [Abstract][Full Text] [Related]
9. Inactivated Kim EJ; Bae J; Ju YJ; Ju DB; Lee D; Son S; Choi H; Ramamurthy T; Yun CH; Kim DW J Microbiol Biotechnol; 2022 Nov; 32(11):1396-1405. PubMed ID: 36317425 [TBL] [Abstract][Full Text] [Related]
10. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses. Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897 [TBL] [Abstract][Full Text] [Related]
11. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens. Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059 [TBL] [Abstract][Full Text] [Related]
12. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera. Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Hakim A; Chowdhury F; Khan AI; Calderwood SB; Harris JB; Ryan ET; Qadri F; Charles RC; Bhuiyan TR mSphere; 2021 Apr; 6(2):. PubMed ID: 33910997 [TBL] [Abstract][Full Text] [Related]
13. Modern History of Cholera Vaccines and the Pivotal Role of icddr,b. Holmgren J J Infect Dis; 2021 Dec; 224(12 Suppl 2):S742-S748. PubMed ID: 34453544 [TBL] [Abstract][Full Text] [Related]
14. Experience with registered mucosal vaccines. Dietrich G; Griot-Wenk M; Metcalfe IC; Lang AB; Viret JF Vaccine; 2003 Jan; 21(7-8):678-83. PubMed ID: 12531339 [TBL] [Abstract][Full Text] [Related]
15. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection. Losonsky GA; Tacket CO; Wasserman SS; Kaper JB; Levine MM Infect Immun; 1993 Feb; 61(2):729-33. PubMed ID: 8423098 [TBL] [Abstract][Full Text] [Related]
17. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909 [TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine. Chac D; Bhuiyan TR; Saha A; Alam MM; Salma U; Jahan N; Chowdhury F; Khan AI; Ryan ET; LaRocque R; Harris JB; Qadri F; Weil AA Infect Immun; 2021 Aug; 89(9):e0021721. PubMed ID: 34228490 [TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice. Tarique AA; Kalsy A; Arifuzzaman M; Rollins SM; Charles RC; Leung DT; Harris JB; Larocque RC; Sheikh A; Bhuiyan MS; Saksena R; Clements JD; Calderwood SB; Qadri F; Kovác P; Ryan ET Clin Vaccine Immunol; 2012 Apr; 19(4):594-602. PubMed ID: 22357651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]